Corbion: Q1 2023 Interim Management Statement
Corbion: Q1 2023 Interim Management Statement
"In a high inflationary environment, we delivered strong growth in Q1 in both Net sales and Adjusted EBITDA. We successfully secured price increases in the course of 2022 as compensation for higher input costs. We are now starting to see some relaxation in input prices.Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the quarter ending 31 March 2023.
在阿姆斯特丹上市的可持續配料公司Corbion倡導通過應用科學進行保護，今天公佈了截至2023年3月31日的季度業績。
Key highlights first quarter of 2023
202年第一季度的主要亮點3.
- Net sales € 359.6 million; an increase of 12.3%, of which organic 8.9%
- Adjusted EBITDA € 48.4 million; an increase of 21.0%, of which organic 18.5%
- Operating profit € 26.9 million; a decline of 10.9% due to last year's book profit of € 9.0 million related to the sale of a US warehouse. Organic growth of 16.5%.
- Core Net sales: organic growth 9.9%, higher prices more than offset a decline in volume/mix
- Core Adjusted EBITDA: organic growth 18.5%
- FY23 outlook improved: core Adjusted EBITDA organic growth at high end of range 15-20%
- 'Advance 2025' strategy implementation on-track
- 淨銷售額3.596億歐元，增長12.3%，其中有機8.9%
- 調整後的EBITDA為4840萬歐元；增長21.0%，其中有機增長18.5%
- 營業利潤2,690萬歐元；下降10.9%，原因是去年與出售美國倉庫有關的賬面利潤為900萬歐元。有機增長16.5%。
- 核心淨銷售額：有機增長9.9%，更高的價格抵消了銷量/組合的下降
- 調整後的核心EBITDA：有機增長18.5%
- 23財年前景改善：核心調整後的EBITDA有機增長在15%-20%的高端
- 《先行2025》戰略實施步入正軌
| € million | Q1 2023 | Q1 2022 | Total growth | Organic growth |
| Net sales | 359.6 | 320.1 | 12.3% | 8.9% |
| Adjusted EBITDA | 48.4 | 40.0 | 21.0% | 18.5% |
| Operating profit | 26.9 | 30.2 | -10.9% | 16.5% |
| Core activities | ||||
| Net sales | 312.5 | 276.2 | 13.1% | 9.9% |
| Adjusted EBITDA | 41.6 | 34.7 | 19.9% | 18.5% |
| 百萬歐元 | 2023年第一季度 | 2022年年第一季度 | 總增長 | 有機增長 |
| 淨銷售額 | 359.6 | 320.1 | 12.3% | 8.9% |
| 調整後的EBITDA | 48.4 | 40.0 | 21.0% | 18.5% |
| 營業利潤 | 26.9 | 30.2 | -10.9% | 16.5% |
| 核心活動 | ||||
| 淨銷售額 | 312.5 | 276.2 | 13.1% | 9.9% |
| 調整後的EBITDA | 41.6 | 34.7 | 19.9% | 18.5% |
Commenting on today's results, Olivier Rigaud, CEO, said:
在評論今天的業績時，首席執行官奧利維爾·裡戈德表示：
"In a high inflationary environment, we delivered strong growth in Q1 in both Net sales and Adjusted EBITDA. We successfully secured price increases in the course of 2022 as compensation for higher input costs. We are now starting to see some relaxation in input prices.
“在高通脹環境下，我們在第一季度實現了淨銷售額和調整後EBITDA的強勁增長。我們成功地在2022年實現了價格上漲，作為對更高投入成本的補償。我們現在開始看到投入價格有所放緩。”
In Sustainable Food Solutions, we have experienced destocking in the value chain, as well as some indications of softening of consumer demand in line with macro conditions. As previously indicated, we expect our expansion plans in product/market adjacencies to contribute to sales growth in the second half of 2023. In Lactic Acid & Specialties, we have seen a continuation of lower levels of sales to the TotalEnergies Corbion joint venture, whilst our Pharma and Biomedical businesses continue to perform well. The Algae Ingredients business has maintained strong and profitable growth, and we have initiated activities to generate additional growth beyond aquaculture.
在可持續食品解決方案中，我們經歷了價值鏈的去庫存，以及一些跡象表明，消費者需求在宏觀條件下出現疲軟。如前所述，我們預計我們在產品/市場鄰近地區的擴張計劃將有助於2023年下半年的銷售增長。在乳酸和特種產品方面，我們看到TotalEnergy Corbion合資企業的銷售額繼續下降，而我們的醫藥和生物醫學業務繼續表現良好。藻類配料業務一直保持強勁和盈利的增長，我們已經啟動了一些活動，以創造水產養殖以外的額外增長。
Building on Corbion's first-quarter performance and despite some challenging circumstances, we are on-track to improve our absolute adjusted EBITDA for the full year, and have accordingly raised our expected growth to the upper end of our 15-20% guidance range. Furthermore, the divestment process of our US emulsifiers business is progressing well, and we anticipate to conclude a transaction before the end of 2023."
在Corbion第一季度業績的基礎上，儘管存在一些挑戰性的情況，我們仍在按計劃改善全年的絕對調整後EBITDA，並相應地將我們的預期增長上調至我們15-20%的指導範圍的上端。此外，我們美國乳化劑業務的撤資過程進展順利，我們預計在2023年底之前完成交易。“
Attachment
依附
- 20230425 Corbion 1Q23 press release ENG
- 20230425 Corbion 1Q23新聞稿英文版
譯文內容由第三人軟體翻譯。
